Loading clinical trials...
Loading clinical trials...
A Clinical Study to Evaluate the Effect of Enlicitide on the Pharmacokinetics of Lithium in Healthy Adult Participants
Conditions
Interventions
lithium carbonate
enlicitide
Locations
1
United States
Celerion ( Site 0002)
Tempe, Arizona, United States
Start Date
January 2, 2025
Primary Completion Date
January 27, 2025
Completion Date
February 6, 2025
Last Updated
February 17, 2025
NCT06716502
NCT06290258
NCT07310264
NCT00090662
NCT07483606
NCT06342713
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions